Archives for January 6, 2009

← 2009

WuXi adopts H-Cube for drug discovery

By Nick Taylor

WuXi AppTec is to use ThalesNano’s H-Cube for laboratory-based hydrogenation, which the CRO believes offers advantages in drug discovery over traditional batch processes.

Europe’s last paracetamol plant closes its doors

By Gareth Macdonald

As 2008 drew to a close and people the world over welcomed the New Year, few would have noticed the passing of Europe’s paracetamol industry as Rhodia closed the doors of the region’s last manufacturing facility in Roussillon, southern France.

Bioreactors may solve platelet shortages

By Phil Taylor

In the future it may be possible to grow supplies of blood platelets in bioreactors rather than relying on donated supplies, according to US researchers.

Endo enters new markets with $370m deal

By Nick Taylor

This year’s M&A activity is underway with Endo’s agreement to acquire Indevus for an initial $370m as it looks to expand beyond the competitive pain market and gain drug delivery technologies.

PPD buys Merck vaccine facility

By Phil Taylor

Contract research organization Pharmaceutical Product Development Inc (PPD) has moved further into providing central laboratory services with the purchase of a 130,000 sq. ft. laboratory from Merck & Co.

Actavis Totowa stops production at out-of-code US plants

By Gareth Macdonald

Actavis Totowa, part of Icelandic generics group Actavis, has agreed to stop selling drugs made at its facilities in New Jersey, US until the plants are made fully compliant with the FDA’s GMP guidelines.

LyondellBasell struggling with debt and global slump

By Gareth Macdonald

LyondellBasell, the world’s third largest petrochemicals firm and a major supplier to the drug industry, is close to bankruptcy according to widespread media reports as it struggles under the weight of a $26bn (€19.4) debt and a slump in demand for its...